NEW YORK (GenomeWeb News) — Genetix last week said it has completed its acquisition of Applied Imaging.
 
Genetix plans to use the company’s protein biomarker hardware and software with its own ClonePix and CloneSelect Imager and reagents to “track the progress of drug discovery” from lab to clinic.
 
Applied Imaging’s Ariol instruments and CytoVision software are used to study tumors at the protein biomarker level to find targets, monitor responses, and predict the how a drug will work.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.